| Literature DB >> 35592184 |
Peter I Legg1, Khalid Malik-Tabassum2, Yasser H Ibrahim3, Baljinder S Dhinsa1.
Abstract
Tibial plafond fractures (TPFs) are uncommon but potentially devastating injuries to the ankle. Operative treatments include internal and external fixation modalities. This article provides a systematic review of the clinical and functional outcomes of TPFs treated specifically with circular external fixation (CEF). A literature search of medical databases from inception to 13th November 2020 was performed. Original studies written in the English language reporting clinical, radiological, and functional outcome data of TPF treated with CEF were included. Patient demographics, fracture classification, open fractures, post-operative complications, clinical outcomes, radiological outcomes, and functional outcomes were collected. Quality and risk of bias were assessed using standardised scoring tools.In total, 16 studies were included. One prospective randomised study was identified. Collated data of 303 patients were analysed. The mean time to union was 21 weeks. Malunion occurred in 12.4%. The rate of deep infection was 4.8%, but no amputations were recorded. The risk of minor soft tissue infection (including pin-site infections) was 54%. Almost two-thirds achieved good-to-anatomic reduction radiologically. Approximately one-third reported excellent functional outcome scores. The quality of the studies was deemed satisfactory. A moderate risk of bias was acknowledged. This systemic review provides a summary of outcome data regarding CEF as a treatment for TPF. It highlights CEF as an acceptable treatment option with comparable results to that of internal fixation. Further higher-quality evidence is advised.Entities:
Keywords: circular external fixator; distal tibia fracture; external fixation; pilon; tibial plafond
Year: 2022 PMID: 35592184 PMCID: PMC9112626 DOI: 10.7759/cureus.24204
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1PRISMA diagram summarising the data collection process.
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Study characteristics by article.
NR denotes data not reported. AO = AO/OTA classification; RA = Ruedi-Allgower classification I, II, III = RA type; B/C = AO/OTA type; AO = Arbeitsgemeinschaft für Osteosynthesefragen; OTA = Orthopedic Trauma Association
| Author | Publication year | cohort size, n | Frame duration, weeks | Time to union, weeks | Non-union | Mal-union | Revision of frame | Minor soft tissue infection | Major soft tissue infection | Osteomyelitis | Nerve injury | Secondary tibiotalar arthrodesis |
|
McDonald et al. [ | 1996 | 13 | 11 | NR | 2 | 0 | 0 | 9 | 0 | 0 | 0 | 1 |
|
Okcu and Aktuglu [ | 2004 | 24 | 16.4 | NR | 0 | 5 | NR | NR | 0 | 0 | NR | 0 |
|
Kapukaya et al. [ | 2005 | 14 | 15 | NR | 0 | 1 | 0 | 17 | 0 | 0 | 0 | 0 |
|
Harris et al. [ | 2006 | 16 | 18 | NR | 1 | 1 | NR | 2 | 1 | 0 | 0 | 1 |
|
Vidyadhara and Rao [ | 2006 | 21 | 26.6 | 26.6 | 0 | 1 | 3 | 7 | 1 | 0 | 0 | NR |
|
Bacon et al. [ | 2008 | 13 | NR | 24.5 | 4 | 3 | 0 | 4 | 1 | 3 | 1 | 1 |
|
Lovisetti et al. [ | 2009 | 30 | 21.4 | 21.4 | 1 | 2 | 1 | 5 | 1 | 0 | NR | 1 |
|
Kholeif et al. [ | 2009 | 15 | 15.9 | NR | 0 | 1 | NR | 10 | 0 | 0 | 0 | NR |
|
Kapoor et al. [ | 2010 | 17 | 17 | 15.8 | 0 | 4 | 1 | 9 | 0 | 0 | 0 | 0 |
|
Ramos et al. [ | 2013 | 18 | 15 | NR | 1 | 4 | 1 | 15 | 11 | 0 | 0 | 1 |
|
Osman et al. [ | 2017 | 30 | 22 | NR | 0 | 4 | 3 | 10 | 0 | 0 | 0 | 1 |
|
Imren et al. [ | 2017 | 20 | NR | 22.1 | 0 | NR | NR | 13 | 1 | 0 | NR | NR |
|
Patra et al. [ | 2017 | 21 | 15.5 | 13.1 | 0 | 3 | 1 | 19 | 0 | 0 | 0 | NR |
|
Sahin et al. [ | 2017 | 14 | NR | 26 | 0 | 2 | 0 | 5 | 0 | 0 | 0 | 0 |
|
Rayan et al. [ | 2018 | 20 | NR | 24.5 | NR | 2 | NR | NR | NR | NR | NR | NR |
|
Pirwani et al. [ | 2018 | 17 | 18 | 14.6 | 0 | NR | 0 | 14 | 8 | 0 | 0 | 0 |
Primary outcome measures.
| Author | Publication year | cohort size, n | Frame duration, weeks | Time to union, weeks | Non-union | Mal-union | Revision of frame | Minor soft tissue infection | Major soft tissue infection | Osteomyelitis | Nerve injury | Secondary tibiotalar arthrodesis |
|
McDonald et al. [ | 1996 | 13 | 11 | NR | 2 | 0 | 0 | 9 | 0 | 0 | 0 | 1 |
|
Okcu and Aktuglu [ | 2004 | 24 | 16.4 | NR | 0 | 5 | NR | NR | 0 | 0 | NR | 0 |
|
Kapukaya et al. [ | 2005 | 14 | 15 | NR | 0 | 1 | 0 | 17 | 0 | 0 | 0 | 0 |
|
Harris et al. [ | 2006 | 16 | 18 | NR | 1 | 1 | NR | 2 | 1 | 0 | 0 | 1 |
|
Vidyadhara and Rao [ | 2006 | 21 | 26.6 | 26.6 | 0 | 1 | 3 | 7 | 1 | 0 | 0 | NR |
|
Bacon et al. [ | 2008 | 13 | NR | 24.5 | 4 | 3 | 0 | 4 | 1 | 3 | 1 | 1 |
|
Lovisetti et al. [ | 2009 | 30 | 21.4 | 21.4 | 1 | 2 | 1 | 5 | 1 | 0 | NR | 1 |
|
Kholeif et al. [ | 2009 | 15 | 15.9 | NR | 0 | 1 | NR | 10 | 0 | 0 | 0 | NR |
|
Kapoor et al. [ | 2010 | 17 | 17 | 15.8 | 0 | 4 | 1 | 9 | 0 | 0 | 0 | 0 |
|
Ramos et al. [ | 2013 | 18 | 15 | NR | 1 | 4 | 1 | 15 | 11 | 0 | 0 | 1 |
|
Osman et al. [ | 2017 | 30 | 22 | NR | 0 | 4 | 3 | 10 | 0 | 0 | 0 | 1 |
|
Imren et al. [ | 2017 | 20 | NR | 22.1 | 0 | NR | NR | 13 | 1 | 0 | NR | NR |
|
Patra et al. [ | 2017 | 21 | 15.5 | 13.1 | 0 | 3 | 1 | 19 | 0 | 0 | 0 | NR |
|
Sahin et al. [ | 2017 | 14 | NR | 26 | 0 | 2 | 0 | 5 | 0 | 0 | 0 | 0 |
|
Rayan et al. [ | 2018 | 20 | NR | 24.5 | NR | 2 | NR | NR | NR | NR | NR | NR |
|
Pirwani et al. [ | 2018 | 17 | 18 | 14.6 | 0 | NR | 0 | 14 | 8 | 0 | 0 | 0 |
Range of motion at the final follow-up.
| Cohort, n | Dorsiflexion, degrees | Plantarflexion, degrees | |
|
Ramos et al. [ | 18 | 17.0 | 19.0 |
|
Kapoor et al. [ | 17 | 9.9 | 30.9 |
|
Osman et al. [ | 30 | 10.0 | 22.5 |
|
Kapukaya et al. [ | 14 | 10.9 | 20.4 |
|
Vidyadhara and Rao [ | 21 | 10.0 | 20.0 |
|
Kholeif et al. [ | 15 | 11.2 | 19.5 |
|
Patra et al. [ | 21 | 10.0 | 31.2 |
|
McDonald et al. [ | 13 | 12.0 | 25.0 |
|
Okcu and Aktuglu [ | 24 | 11.3 | 33.5 |
|
Sahin et al. [ | 14 | 15.5 | 26.1 |
Functional outcome scores.
MMAS (Modified Mazur Ankle Score) score stratification: Excellent >92, Good 87-91, Fair 65-86, Poor <65.
AOFAS (American Orthopedic Foot and Ankle Society) score stratification: not reported.
| n | Average score | Scoring system | |
|
Kapoor et al. [ | 16 | 79.8 | MMAS |
|
Okcu and Aktuglu [ | 24 | 86.6 | MMAS |
|
Imren et al. [ | 20 | 79.6 | AOFAS |
|
Rayan et al. [ | 20 | 86.7 | AOFAS |
|
Patra et al. [ | 21 | 76.3 | AOFAS |
|
Sahin et al. [ | 14 | 80.4 | AOFAS |
Radiological outcome scores.
| Teeny & Wiss criteria | |||||
| cohort size, n | Anatomic | Good | Fair | Poor | |
|
Osman et al. [ | 30 | 5 | 15 | 6 | 4 |
|
Lovisetti et al. [ | 30 | 5 | 23 | 2 | 0 |
|
Kholeif et al. [ | 15 | 1 | 9 | 4 | 1 |
|
Kapukaya et al. [ | 14 | 4 | 6 | 2 | 2 |
| Articular gap, mm | |||||
| Good, <2 mm | Fair, 2-4 mm | Poor, >4 mm | |||
|
Kapoor et al. [ | 17 | 5 | 10 | 1 | |
|
Patra et al. [ | 21 | 7 | 14 | 0 | |
Quality scores of comparative studies.
MINORS = Methodological Index for Non-Randomized Studies
| MINORS tool | |||||
|
Okcu and Aktuglu 2004 [ |
Harris et al., 2006 [ |
Bacon et al., 2008 [ |
Imren et al., 2017 [ |
Patra et al., 2017 [ | |
| Clearly stated aim | 2 | 2 | 2 | 2 | 2 |
| Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 |
| prospective collection of data | 0 | 0 | 0 | 0 | 0 |
| End-points appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 |
| Unbiased assessment of the study endpoint | 0 | 0 | 0 | 0 | 0 |
| Follow-up period appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 |
| Loss to follow-up <5% | 1 | 2 | 0 | 2 | 1 |
| Prospective calculation of study size | 0 | 0 | 2 | 0 | 0 |
| Adequate control group | 2 | 2 | 2 | 2 | 2 |
| Contemporary groups | 2 | 2 | 2 | 2 | 2 |
| Baseline equivalence of groups | 2 | 0 | 2 | 2 | 0 |
| Adequate statistical analysis | 2 | 2 | 2 | 2 | 2 |
| Total | 17 | 16 | 18 | 18 | 15 |
Risk of bias for randomised study.
ROB-2 = Risk of Bias 2
| ROB-2 tool | |
|
Rayan et al., 2018 [ | |
| Risk of bias arising from the randomisation process | Low |
| Risk of bias due to deviations from the intended intervention | Low |
| Missing outcome data | Low |
| Risk of bias in the measurement of outcome | Low |
| Risk of bias in the selection of reported results | Moderate |
| Overal risk of bias | Low |
Risk of bias for non-randomised trials.
ROBINS-I = Non-Randomised Studies - of Interventions
| ROBINS-I | |||||
|
Okcu and Aktuglu 2004 [ |
Harris et al., 2006 [ |
Bacon et al., 2008 [ |
Imren et al., 2017 [ |
Patra et al., 2017 [ | |
| Bias due to confounding | Moderate | Moderate | Moderate | Moderate | Moderate |
| Bias in selection of participants into the study | Serious | Serious | Serious | Serious | Serious |
| Bias in classification of interventions | Moderate | Moderate | Moderate | Moderate | Serious |
| Bias due to deviation from intended interventions | Moderate | Moderate | Moderate | Moderate | Moderate |
| Bias due to missing data | Serious | Low | Moderate | Low | Moderate |
| Bias in measurement of outcomes | Moderate | Moderate | Moderate | Moderate | Moderate |
| Bias in selection of the reported outcomes | Low | Low | Moderate | Moderate | Moderate |
| Overall judgement of bias | Moderate | Moderate | Moderate | Moderate | Moderate |